Global Digital Biomarkers Market 2020-2030 by System Component, Therapeutic Area, Application, Development Status, End User, and Region: Trend Forecast and Growth Opportunity

About the Report

About the Report

Global digital biomarkers market will reach USD 22.54 billion by 2030, growing by 36.2% annually over 2020-2030 driven by rising demand for mobile health apps, elevated level of smartphone and wearable technology in healthcare.

Highlighted with 91 tables and 99 figures, this 199-page report Global Digital Biomarkers Market 2020-2030 by System Component, Therapeutic Area, Application, Development Status, End User, and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global digital biomarkers market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global digital biomarkers market in every aspect of the classification from perspectives of System Component, Therapeutic Area, Application, Development Status, End User, and Region.

Based on System Component, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Data Collection Tools

Digital Platforms

Mobile Apps

Desktop-based Software

Wearables

Biosensors

Data Integration Systems

Based on Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Cardiovascular Diseases

Neurodegenerative Disorders

Parkinson's Disease

Multiple Sclerosis

Alzheimer's Disease

Sleep and Movement Diseases

Psychiatric Disorders

Chronic Pain

Gastrointestinal Diseases

Diabetes

Respiratory Conditions

Other Diseases

Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Wellness

Disease Diagnosis

Personalised Medication

Drug Discovery and Development

Based on Development Status, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Novel Digital Biomarkers

Original Digital Biomarkers

Approved Digital Biomarkers

Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Biopharmaceutical Companies & Labs

Healthcare Providers

Insurance Payers

Geographically, the following regions together with the listed national/local markets are fully investigated:

APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)

Europe (Germany, UK, France, The Netherlands, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, Spain, Poland, Czech Republic, Slovakia, Hungary, and Romania)

North America (U.S., Canada, and Mexico)

South America (Brazil, Chile, Argentina, Rest of South America)

RoW (Saudi Arabia, UAE, Israel)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by System Component, Therapeutic Area, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global digital biomarkers market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

Actigraph LLC

Akili Interactive Labs

AliveCor Inc

Altoida Inc

Amgen Inc

Bayer AG

Biogen Inc

Cambridge Cognition Plc

Eli Lilly and Company

Evidation Health, Inc.

F. Hoffmann-La Roche Ltd

Fitbit Inc

GlaxoSmithKline Plc

Happify Health

Human API

IXICO Plc

Koninklijke Philips N.V.

Medical Care Corporation

Medopad Ltd

Mindstrong Health

Neurotrack Technology, Inc

Novartis International AG

Pfizer Inc.

Quanterix Corporation

Sanofi S.A.

The Takeda Pharmaceuticals Company Limited

Verily Life Sciences

Winterlight Labs Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Products


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

Actigraph LLC

Akili Interactive Labs

AliveCor Inc

Altoida Inc

Amgen Inc

Bayer AG

Biogen Inc

Cambridge Cognition Plc

Eli Lilly and Company

Evidation Health, Inc.

F. Hoffmann-La Roche Ltd

Fitbit Inc

GlaxoSmithKline Plc

Happify Health

Human API

IXICO Plc

Koninklijke Philips N.V.

Medical Care Corporation

Medopad Ltd

Mindstrong Health

Neurotrack Technology, Inc

Novartis International AG

Pfizer Inc.

Quanterix Corporation

Sanofi S.A.

The Takeda Pharmaceuticals Company Limited

Verily Life Sciences

Winterlight Labs Inc.

Table of Contents

Table of Contents

1 Introduction 10

1.1 Industry Definition and Research Scope 10

1.1.1 Industry Definition 10

1.1.2 Research Scope 11

1.2 Research Methodology 14

1.2.1 Overview of Market Research Methodology 14

1.2.2 Market Assumption 15

1.2.3 Secondary Data 15

1.2.4 Primary Data 15

1.2.5 Data Filtration and Model Design 17

1.2.6 Market Size/Share Estimation 18

1.2.7 Research Limitations 19

1.3 Executive Summary 20

2 Market Overview and Dynamics 23

2.1 Market Size and Forecast 23

2.1.1 Impact of COVID-19 on the Market 28

2.2 Major Growth Drivers 30

2.3 Market Restraints and Challenges 35

2.4 Emerging Opportunities and Market Trends 40

2.5 Porter's Fiver Forces Analysis 44

3 Segmentation of Global Market by System Component 48

3.1 Market Overview by System Component 48

3.2 Data Collection Tools 50

3.2.1 Digital Platforms 52

3.2.2 Mobile Apps 53

3.2.3 Desktop-based Software 54

3.2.4 Wearables 55

3.2.5 Biosensors 56

3.3 Data Integration Systems 57

4 Segmentation of Global Market by Therapeutic Area 58

4.1 Market Overview by Therapeutic Area 58

4.2 Cardiovascular Diseases 60

4.3 Neurodegenerative Disorders 61

4.3.1 Parkinson's Disease 63

4.3.2 Multiple Sclerosis 64

4.3.3 Alzheimer's Disease 65

4.4 Sleep and Movement Diseases 66

4.5 Psychiatric Disorders 67

4.6 Chronic Pain 68

4.7 Gastrointestinal Diseases 69

4.8 Diabetes 70

4.9 Respiratory Conditions 71

4.10 Other Diseases 72

5 Segmentation of Global Market by Application 73

5.1 Market Overview by Application 73

5.2 Wellness 75

5.3 Disease Diagnosis 76

5.4 Personalised Medication 77

5.5 Drug Discovery and Development 78

6 Segmentation of Global Market by Development Status 80

6.1 Market Overview by Development Status 80

6.2 Novel Digital Biomarkers 83

6.3 Original Digital Biomarkers 84

6.4 Approved Digital Biomarkers 85

7 Segmentation of Global Market by End User 86

7.1 Market Overview by End User 86

7.2 Biopharmaceutical Companies & Labs 88

7.3 Healthcare Providers 89

7.4 Insurance Payers 90

8 Segmentation of Global Market by Region 91

8.1 Geographic Market Overview 2019-2030 91

8.2 North America Market 2019-2030 by Country 95

8.2.1 Overview of North America Market 95

8.2.2 U.S. 99

8.2.3 Canada 103

8.2.4 Mexico 105

8.3 European Market 2019-2030 by Country 107

8.3.1 Overview of European Market 107

8.3.2 Germany 111

8.3.3 UK 113

8.3.4 France 115

8.3.5 Netherlands 117

8.3.6 Italy 119

8.3.7 Russia 121

8.3.8 Rest of European Market 123

8.4 Asia-Pacific Market 2019-2030 by Country 125

8.4.1 Overview of Asia-Pacific Market 125

8.4.2 Japan 129

8.4.3 China 132

8.4.4 Australia 134

8.4.5 India 136

8.4.6 South Korea 138

8.4.7 Rest of APAC Region 140

8.5 South America Market 2019-2030 by Country 142

8.5.1 Argentina 145

8.5.2 Brazil 147

8.5.3 Chile 149

8.5.4 Rest of South America Market 151

8.6 MEA Market 2019-2030 by Country 152

8.6.1 UAE 155

8.6.2 Saudi Arabia 157

8.6.3 Israel 159

8.6.4 Other National Markets 161

9 Competitive Landscape 162

9.1 Overview of Key Vendors 162

9.2 New Product Launch, Partnership, Investment, and M&A 166

9.3 Company Profiles 167

Actigraph LLC 167

Akili Interactive Labs 169

AliveCor Inc 170

Altoida Inc 171

Amgen Inc 172

Bayer AG 173

Biogen Inc 174

Cambridge Cognition Plc 175

Eli Lilly and Company 176

Evidation Health, Inc. 177

F. Hoffmann-La Roche Ltd 178

Fitbit Inc 179

GlaxoSmithKline Plc 180

Happify Health 181

Human API 182

IXICO Plc 183

Koninklijke Philips N.V. 184

Medical Care Corporation 185

Medopad Ltd 186

Mindstrong Health 187

Neurotrack Technology, Inc 188

Novartis International AG 189

Pfizer Inc. 190

Quanterix Corporation 191

Sanofi S.A. 192

The Takeda Pharmaceuticals Company Limited 193

Verily Life Sciences 194

Winterlight Labs Inc. 195

10 Investing in Global Market: Risk Assessment and Management 196

10.1 Risk Evaluation of Global Market 196

10.2 Critical Success Factors (CSFs) 199

Related Reports and Products 199


List of Figure

Figure 1. Research Method Flow Chart 14

Figure 2. Breakdown of Primary Research 16

Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 18

Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 20

Figure 5. Global Digital Biomarkers Market, 2019-2030, USD mn 23

Figure 6. Category and Relationship of Traditional Biomarkers and Digital Biomarkers 24

Figure 7. Benefits and Challenges of Digital Biomarkers 26

Figure 8. Global Biomarkers Market, 2019-2030, USD mn 27

Figure 9. Share of Digital Biomarkers in Total Biomarkers Market, 2019-2030 27

Figure 10. Impact of COVID-19 on Business 28

Figure 11. Primary Drivers and Impact Factors of Global Digital Biomarkers Market 30

Figure 12. World 5G Traffic, 2019-2030, EB/year 33

Figure 13. Primary Restraints and Impact Factors of Global Digital Biomarkers Market 35

Figure 14. Data Security Risk in Various User Groups of Digital Biomarkers 38

Figure 15. Pathway to Regulatory Approval of Digital Biomarkers 39

Figure 16. Investment Opportunity Analysis 41

Figure 17. Porter's Fiver Forces Analysis of Global Digital Biomarkers Market 44

Figure 18. Breakdown of Global Digital Biomarkers Market by System Component, 2019-2030, % of Revenue 49

Figure 19. Global Addressable Market Cap in 2020-2030 by System Component, Value (USD mn) and Share (%) 49

Figure 20. Global Digital Biomarkers Market: Data Collection Tools, 2019-2030, USD mn 50

Figure 21. Global Digital Biomarkers Market: Digital Platforms, 2019-2030, USD mn 52

Figure 22. Global Digital Biomarkers Market: Mobile Apps, 2019-2030, USD mn 53

Figure 23. Global Digital Biomarkers Market: Desktop-based Software, 2019-2030, USD mn 54

Figure 24. Global Digital Biomarkers Market: Wearables, 2019-2030, USD mn 55

Figure 25. Global Digital Biomarkers Market: Biosensors, 2019-2030, USD mn 56

Figure 26. Global Digital Biomarkers Market: Data Integration Systems, 2019-2030, USD mn 57

Figure 27. Breakdown of Global Digital Biomarkers Market by Therapeutic Area, 2019-2030, % of Sales Revenue 59

Figure 28. Global Addressable Market Cap in 2020-2030 by Therapeutic Area, Value (USD mn) and Share (%) 59

Figure 29. Global Digital Biomarkers Market: Cardiovascular Diseases, 2019-2030, USD mn 60

Figure 30. Global Digital Biomarkers Market: Neurodegenerative Disorders, 2019-2030, USD mn 61

Figure 31. Global Digital Biomarkers Market: Parkinson's Disease, 2019-2030, USD mn 63

Figure 32. Global Digital Biomarkers Market: Multiple Sclerosis, 2019-2030, USD mn 64

Figure 33. Global Digital Biomarkers Market: Alzheimer's Disease, 2019-2030, USD mn 65

Figure 34. Global Digital Biomarkers Market: Sleep and Movement Diseases, 2019-2030, USD mn 66

Figure 35. Global Digital Biomarkers Market: Psychiatric Disorders, 2019-2030, USD mn 67

Figure 36. Global Digital Biomarkers Market: Chronic Pain, 2019-2030, USD mn 68

Figure 37. Global Digital Biomarkers Market: Gastrointestinal Diseases, 2019-2030, USD mn 69

Figure 38. Global Digital Biomarkers Market: Diabetes, 2019-2030, USD mn 70

Figure 39. Global Digital Biomarkers Market: Respiratory Conditions, 2019-2030, USD mn 71

Figure 40. Global Digital Biomarkers Market: Other Diseases, 2019-2030, USD mn 72

Figure 41. Breakdown of Global Digital Biomarkers Market by Application, 2019-2030, % of Sales Revenue 74

Figure 42. Global Addressable Market Cap in 2020-2030 by Application, Value (USD mn) and Share (%) 74

Figure 43. Global Digital Biomarkers Market: Wellness, 2019-2030, USD mn 75

Figure 44. Global Digital Biomarkers Market: Disease Diagnosis, 2019-2030, USD mn 76

Figure 45. Global Digital Biomarkers Market: Personalised Medication, 2019-2030, USD mn 77

Figure 46. Global Digital Biomarkers Market: Drug Discovery and Development, 2019-2030, USD mn 78

Figure 47. Classification of Digital Biomarkers by Development Status 80

Figure 48. Breakdown of Global Digital Biomarkers Market by Development Status, 2019-2030, % of Revenue 82

Figure 49. Global Addressable Market Cap in 2020-2030 by Development Status, Value (USD mn) and Share (%) 82

Figure 50. Global Digital Biomarkers Market: Novel Digital Biomarkers, 2019-2030, USD mn 83

Figure 51. Global Digital Biomarkers Market: Original Digital Biomarkers, 2019-2030, USD mn 84

Figure 52. Global Digital Biomarkers Market: Approved Digital Biomarkers, 2019-2030, USD mn 85

Figure 53. Breakdown of Global Digital Biomarkers Market by End User, 2019-2030, % of Revenue 87

Figure 54. Global Addressable Market Cap in 2020-2030 by End User, Value (USD mn) and Share (%) 87

Figure 55. Global Digital Biomarkers Market: Biopharmaceutical Companies & Labs, 2019-2030, USD mn 88

Figure 56. Global Digital Biomarkers Market: Healthcare Providers, 2019-2030, USD mn 89

Figure 57. Global Digital Biomarkers Market: Insurance Payers, 2019-2030, USD mn 90

Figure 58. Global Market Snapshot by Region 91

Figure 59. Geographic Spread of Worldwide Digital Biomarkers Market, 2019-2030, % of Sales Revenue 92

Figure 60. Global Addressable Market Cap in 2020-2030 by Region, Value (USD mn) and Share (%) 93

Figure 61. North American Digital Biomarkers Market, 2019-2030, USD mn 96

Figure 62. Breakdown of North America Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue 97

Figure 63. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value (USD mn) and Share (%) 98

Figure 64. U.S. Digital Biomarkers Market, 2019-2030, USD mn 100

Figure 65. Canada Digital Biomarkers Market, 2019-2030, USD mn 103

Figure 66. Digital Biomarkers Market in Mexico, 2015-2030, USD mn 105

Figure 67. European Digital Biomarkers Market, 2019-2030, USD mn 108

Figure 68. Breakdown of European Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue 109

Figure 69. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value (USD mn) and Share (%) 110

Figure 70. Digital Biomarkers Market in Germany, 2019-2030, USD mn 111

Figure 71. Digital Biomarkers Market in UK, 2019-2030, USD mn 113

Figure 72. Digital Biomarkers Market in France, 2019-2030, USD mn 115

Figure 73. Digital Biomarkers Market in Netherlands, 2019-2030, USD mn 117

Figure 74. Digital Biomarkers Market in Italy, 2019-2030, USD mn 119

Figure 75. Digital Biomarkers Market in Russia, 2019-2030, USD mn 121

Figure 76. Digital Biomarkers Market in Rest of Europe, 2019-2030, USD mn 123

Figure 77. Asia-Pacific Digital Biomarkers Market, 2019-2030, USD mn 126

Figure 78. Breakdown of APAC Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue 126

Figure 79. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value (USD mn) and Share (%) 128

Figure 80. Digital Biomarkers Market in Japan, 2019-2030, USD mn 130

Figure 81. Digital Biomarkers Market in China, 2019-2030, USD mn 132

Figure 82. Digital Biomarkers Market in Australia, 2019-2030, USD mn 134

Figure 83. Digital Biomarkers Market in India, 2019-2030, USD mn 136

Figure 84. Digital Biomarkers Market in South Korea, 2019-2030, USD mn 138

Figure 85. Digital Biomarkers Market in Rest of APAC, 2019-2030, USD mn 140

Figure 86. South America Digital Biomarkers Market, 2019-2030, USD mn 143

Figure 87. Breakdown of South America Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue 143

Figure 88. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value (USD mn) and Share (%) 144

Figure 89. Digital Biomarkers Market in Argentina, 2019-2030, USD mn 145

Figure 90. Digital Biomarkers Market in Brazil, 2019-2030, USD mn 147

Figure 91. Digital Biomarkers Market in Chile, 2019-2030, USD mn 149

Figure 92. Digital Biomarkers Market in Rest of South America, 2019-2030, USD mn 151

Figure 93. Digital Biomarkers Market in Middle East and Africa (MEA), 2019-2030, USD mn 153

Figure 94. Breakdown of MEA Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue 153

Figure 95. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value (USD mn) and Share (%) 154

Figure 96. Digital Biomarkers Market in UAE, 2019-2030, USD mn 155

Figure 97. Digital Biomarkers Market in Saudi Arabia, 2019-2030, USD mn 157

Figure 98. Digital Biomarkers Market in Israel, 2019-2030, USD mn 159

Figure 99. Growth Stage of Global Digital Biomarkers Industry over the Forecast Period 162


List of Table

Table 1. Snapshot of Global Digital Biomarkers Market, 2019-2030 21

Table 2. Overview of Traditional and Digital Biomarker Features, Novel Applications, and Published Examples 25

Table 3. World Smartphone Connections, Average Network Connection Speed for Smartphones and Tablets, 2019-2030 33

Table 4. World Mobile Data Traffic by Deployment Mode, 2019-2030, EB/year 34

Table 5. World Mobile Data Traffic by Device, 2019-2030, EB/year 34

Table 6. Current Challenges of Digital Biomarkers in Medical Settings 37

Table 7. Main Product Trends and Market Opportunities in Global Digital Biomarkers Market 40

Table 8. Global Digital Biomarkers Market by System Component, 2019-2030, USD mn 48

Table 9. Global Digital Biomarkers Market: Data Collection Tools by Type, 2019-2030, USD mn 51

Table 10. Global Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 58

Table 11. Global Digital Biomarkers Market: Neurodegenerative Disorders by Type, 2019-2030, USD mn 62

Table 12. Global Digital Biomarkers Market by Application, 2019-2030, USD mn 73

Table 13. Global Digital Biomarkers Market by Development Status, 2019-2030, USD mn 81

Table 14. Global Digital Biomarkers Market by End User, 2019-2030, USD mn 86

Table 15. Global Digital Biomarkers Market by Region, 2019-2030, USD mn 92

Table 16. Leading National Digital Biomarkers Market, 2019 and 2030, USD mn 94

Table 17. North America Digital Biomarkers Market by Country, 2019-2030, USD mn 97

Table 18. U.S. Digital Biomarkers Market by System Component, 2019-2030, USD mn 101

Table 19. U.S. Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 101

Table 20. U.S. Digital Biomarkers Market by End User, 2019-2030, USD mn 101

Table 21. Canada Digital Biomarkers Market by System Component, 2019-2030, USD mn 104

Table 22. Canada Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 104

Table 23. Canada Digital Biomarkers Market by End User, 2019-2030, USD mn 104

Table 24. Mexico Digital Biomarkers Market by System Component, 2019-2030, USD mn 106

Table 25. Mexico Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 106

Table 26. Mexico Digital Biomarkers Market by End User, 2019-2030, USD mn 106

Table 27. Europe Digital Biomarkers Market by Country, 2019-2030, USD mn 110

Table 28. Germany Digital Biomarkers Market by System Component, 2019-2030, USD mn 112

Table 29. Germany Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 112

Table 30. Germany Digital Biomarkers Market by End User, 2019-2030, USD mn 112

Table 31. UK Digital Biomarkers Market by System Component, 2019-2030, USD mn 114

Table 32. UK Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 114

Table 33. UK Digital Biomarkers Market by End User, 2019-2030, USD mn 114

Table 34. France Digital Biomarkers Market by System Component, 2019-2030, USD mn 116

Table 35. France Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 116

Table 36. France Digital Biomarkers Market by End User, 2019-2030, USD mn 116

Table 37. Netherlands Digital Biomarkers Market by System Component, 2019-2030, USD mn 118

Table 38. Netherlands Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 118

Table 39. Netherlands Digital Biomarkers Market by End User, 2019-2030, USD mn 118

Table 40. Italy Digital Biomarkers Market by System Component, 2019-2030, USD mn 120

Table 41. Italy Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 120

Table 42. Italy Digital Biomarkers Market by End User, 2019-2030, USD mn 120

Table 43. Russia Digital Biomarkers Market by System Component, 2019-2030, USD mn 122

Table 44. Russia Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 122

Table 45. Russia Digital Biomarkers Market by End User, 2019-2030, USD mn 122

Table 46. Digital Biomarkers Market in Rest of Europe by Country, 2019-2030, USD mn 124

Table 47. APAC Digital Biomarkers Market by Country, 2019-2030, USD mn 127

Table 48. Japan Digital Biomarkers Market by System Component, 2019-2030, USD mn 131

Table 49. Japan Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 131

Table 50. Japan Digital Biomarkers Market by End User, 2019-2030, USD mn 131

Table 51. China Digital Biomarkers Market by System Component, 2019-2030, USD mn 133

Table 52. China Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 133

Table 53. China Digital Biomarkers Market by End User, 2019-2030, USD mn 133

Table 54. Australia Digital Biomarkers Market by System Component, 2019-2030, USD mn 135

Table 55. Australia Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 135

Table 56. Australia Digital Biomarkers Market by End User, 2019-2030, USD mn 135

Table 57. India Digital Biomarkers Market by System Component, 2019-2030, USD mn 137

Table 58. India Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 137

Table 59. India Digital Biomarkers Market by End User, 2019-2030, USD mn 137

Table 60. South Korea Digital Biomarkers Market by System Component, 2019-2030, USD mn 139

Table 61. South Korea Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 139

Table 62. South Korea Digital Biomarkers Market by End User, 2019-2030, USD mn 139

Table 63. Digital Biomarkers Market in Rest of APAC by Country, 2019-2030, USD mn 141

Table 64. South America Digital Biomarkers Market by Country, 2019-2030, USD mn 144

Table 65. Argentina Digital Biomarkers Market by System Component, 2019-2030, USD mn 146

Table 66. Argentina Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 146

Table 67. Argentina Digital Biomarkers Market by End User, 2019-2030, USD mn 146

Table 68. Brazil Digital Biomarkers Market by System Component, 2019-2030, USD mn 148

Table 69. Brazil Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 148

Table 70. Brazil Digital Biomarkers Market by End User, 2019-2030, USD mn 148

Table 71. Chile Digital Biomarkers Market by System Component, 2019-2030, USD mn 150

Table 72. Chile Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 150

Table 73. Chile Digital Biomarkers Market by End User, 2019-2030, USD mn 150

Table 74. MEA Digital Biomarkers Market by Country, 2019-2030, USD mn 154

Table 75. UAE Digital Biomarkers Market by System Component, 2019-2030, USD mn 156

Table 76. UAE Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 156

Table 77. UAE Digital Biomarkers Market by End User, 2019-2030, USD mn 156

Table 78. Saudi Arabia Digital Biomarkers Market by System Component, 2019-2030, USD mn 158

Table 79. Saudi Arabia Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 158

Table 80. Saudi Arabia Digital Biomarkers Market by End User, 2019-2030, USD mn 158

Table 81. Israel Digital Biomarkers Market by System Component, 2019-2030, USD mn 160

Table 82. Israel Digital Biomarkers Market by Therapeutic Area, 2019-2030, USD mn 160

Table 83. Israel Digital Biomarkers Market by End User, 2019-2030, USD mn 160

Table 84. Breakdown of Global Market by Key Vendor, 2019, % 164

Table 85. Actigraph LLC: Company Snapshot 167

Table 86. Actigraph LLC: Business Segmentation 167

Table 87. Actigraph LLC: Product Portfolio 168

Table 88. Actigraph LLC: Revenue, 2016-2018, USD mn 168

Table 89. Actigraph LLC: Recent Developments 168

Table 90. Risk Evaluation for Investing in Global Market, 2019-2030 197

Table 91. Critical Success Factors and Key Takeaways 200

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022

What Our Clients Say About Us

Want the same for your business? Talk To Our Expert